Results shows equal sensitivity to culture and article highlights the usability of GenomEra.
From the conclusions: “GenomEra GBS PCR assay has potential as an easy and rapid on-site test for intrapartum detection of vaginal carriage of GBS at a maternity ward to identify women in labor who should receive intrapartum antibiotic prophylaxis.”
Abacus Diagnostica´s GenomEra Flu A/B + RSV is now CE IVD approved and available! To discuss more about our new product, come and meet us at ECCMID 2019 in Amsterdam, booth 1.148!
Analyte PPA (i.e. sensitivity) NPA (i.e. specificity) Accuracy
Flu A (n=1256) 97.1% 99.4% 98.6%
Flu B (n=1256) 100% 100% 100%
RSV (n=701) 98% 99.8% 98.7%
Overall accuracy: 99.3%
Abacus Diagnostica is exhibiting at ECCMID 2019. Contact us to book your meeting with the team to hear the latest news! See you in few weeks at booth #1.148!
Come and meet us at Labquality Days 2019 in Helsinki Conference Centre during 7-8th of February! We will be exhibiting at stand S1 and happy to answer questions concerning our upcoming FLU A/B + RSV.
We are proud to announce our new distributors as follows:
- Intuitive Technology Ltd covering Hong Kong and Macau,
- Medicon Hellas S.A. covering Greece
- Triolab Baltic OÜ covering Estonia, Lithuania and Latvia
- HVD Life Sciences covering Israel, Lebanon, Egypt, Jordan, Oman and United Arab Emirates
- Bergman Diagnostika A/S covering Norway
Please visit www.abacusdiagnostica.com/distributors to view the the complete list.
Meet us at Medica 2018 in Düsseldorf 12-15.11.2018. Please contact email@example.com to schedule a meeting.
We are completing our new test Influenza A/B & RSV and we will start evaluations during November 2018. If you are interested, please contact us.
Our CEO Erno Sundberg will be present at the ESCV 2018 event. He will be available during the whole time. Come and collect the latest updates on our influenza A/B & RSV tests.